Health Trials

The Long COVID-19 Wearable Device Study

ConditionsLong COVIDPostural Orthostatic Tachycardia SyndromeDysautonomiaMyalgic EncephalomyelitisChronic Fatigue SyndromeLong Covid19
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorScripps Translational Science Institute

About this trial

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

Eligibility criteria

Qualifiers

Is at least 18 years old.

Long COVID (based on the WHO working definition),

ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or

POTS (Postural Orthostatic Tachycardia Syndrome).

Disqualifiers

As long as they meet inclusion there is no exclusion

Trial design

Treatments tested in this trial

  • Wearable device

Treatment groups

100,500 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Scripps Translational Science Institute

Lead sponsor

Source ClinicalTrials.gov